Baxter Beats on Q3 Sales of $2.98B, Raises Full-Year 2026 Outlook
BAX sits 70% above its 52-week low of $15.73 on elevated volume (1.9× avg).
Summary
Baxter posted Q3 sales of $2.98 billion, up 5% organic, with adjusted EPS of $0.58, and raised its full-year 2026 sales and adjusted EPS outlook.
Key Events · Earnings and Guidance · BAX
-
Q3 Sales Rise 5% to $2.98B
Worldwide sales of approximately $2.98 billion increased 5% on both a reported and organic basis, with growth across all segments and divisions.
-
Adjusted EPS Falls 16% on Tax Rate
GAAP diluted EPS was $0.57 and adjusted diluted EPS was $0.58, down 16% year over year due to a higher effective tax rate.
-
Full-Year 2026 Outlook Raised
Reported sales growth guidance raised to 4%-5% from 3%-4%, organic growth to 3%-4% from 2%-3%, and adjusted diluted EPS to $2.05-$2.15 from $1.95-$2.15.
-
Free Cash Flow and Debt Paydown
Free cash flow was $448 million in the quarter and $705 million year-to-date; the company completed a $600 million cash tender offer, retiring $864 million of debt.
Analysis · BAX · Industrial Applications And Services
Baxter grew third-quarter sales 5% on both a reported and organic basis to $2.98 billion, with growth in every segment and division, and GAAP diluted EPS of $0.57. The company raised its full-year outlook: reported sales growth to 4%-5% from 3%-4%, organic growth to 3%-4% from 2%-3%, and adjusted diluted EPS to $2.05-$2.15 from $1.95-$2.15. Adjusted EPS of $0.58 fell 16% year over year on a higher effective tax rate, so the raise is a revenue and cash story rather than a margin recovery. Free cash flow of $448 million in the quarter and $705 million year-to-date, plus $864 million of debt retired in the quarter, supports the deleveraging and investment-grade credit objectives management has been pursuing.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BAX was trading at $26.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $15.73 to $30.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.